UNSPSC 51113503: Venetoclax

Venetoclax is a medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML).

UNSPSC 51113503 Venetoclax, a Commodity code, does not align with the state and local procurement opportunities posted under this classification. The recent opportunities show no purchase or procurement of venetoclax, an oral anticancer medication used to treat chronic lymphocytic leukemia and acute myeloid leukemia. Instead, the opportunities tagged to this code span emergency medical services drug distribution (BLS/ALS pharmaceuticals and supplies via the City of Tucson Fire Department), long-term care pharmacy services (Dane County's Badger Prairie Health Care Center), mental health facility prescription services (West Texas Centers), community health drug-distribution programs (naloxone and safe drug deactivation systems via Seminole County, Florida), forensic laboratory drug reference standards (Pinellas County, Florida), and EMS protocol software (Collier County's Handtevy application). A District of Columbia pharmacy benefits program network qualification and a Washington County, Oregon naloxone distribution center letter of interest round out the posted activity. These procurements address drug dispensing, pharmacy management, emergency-medicine supply chains, and community health initiatives—not oncology pharmaceutical procurement.

No state or local jurisdiction has solicited venetoclax specifically in recent months. The code appears to have been applied to opportunities in which drugs and pharmaceutical-related services are purchased, but the specific product—venetoclax—sees no active state and local demand captured in the recent-opportunities block. Business development professionals evaluating this code should confirm whether venetoclax demand exists within target jurisdictions' oncology services, specialty pharmacy networks, or correctional healthcare programs before allocating pursuit resources. The mismatch between the code's nominal scope and actual procurement activity suggests either tagging error or that venetoclax procurement, if it occurs at the state and local level, flows through broader pharmacy services contracts rather than standalone product purchases.